论文部分内容阅读
目的探讨依达拉奉治疗急性脑梗死的疗效。方法将100例急性脑梗死患者随机分为治疗组和对照组,每组各50例,对照组用常规治疗方法,治疗组在常规治疗的基础上加用依达拉奉注射液,进行疗效评定。结果治疗组总有效率(84%)明显优于对照组(64%),神经功能缺损评分改善显著(P<0.05),治疗组和对照组的起效时间相比,治疗组明显早于对照组,差异有显著性。结论依达拉奉注射液能有效改善急性脑梗死的神经功能缺失和日常生活能力,并能更好地控制脑梗死的进展。
Objective To investigate the efficacy of edaravone in the treatment of acute cerebral infarction. Methods 100 patients with acute cerebral infarction were randomly divided into treatment group and control group, 50 cases in each group. The control group was treated with conventional treatment. The treatment group was treated with edaravone injection on the basis of routine treatment, and the curative effect was evaluated . Results The total effective rate (84%) in the treatment group was significantly better than that in the control group (64%), and the neurological deficit score improved significantly (P <0.05). The onset time in the treatment group was significantly earlier than that in the control group Group, the difference was significant. Conclusion Edaravone injection can effectively improve the neurological deficits and daily living ability of acute cerebral infarction and can better control the progress of cerebral infarction.